Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial
bioRxiv (2021) - Comments
doi: 10.1101/2021.11.22.21266690 

Marisa Holubar, Aruna Subramanian, Natasha Purington, Haley Hedlin, Bryan Bunning, Katharine S. Walter, Hector Bonilla, Athanasia Boumis, Michael Chen, Kimberly Clinton, Liisa Dewhurst, Carol Epstein, Prasanna Jagannathan, Richard H. Kaszynski, Lori Panu, Julie Parsonnet, Elizabeth L. Ponder, Orlando Quintero, Elizabeth Sefton, Upinder Singh